Referrals
search
eNewsletter HealthPoints Sign up for our HealthPoints E-Newsletter
Department of Surgery
info@columbiasurgery.org Referrals Patient Clinician Researcher
Tumor Vaccines
About Tumor Vaccines
Treatment Approaches
Clinical Trials
IL-2
Melanoma Center
FAQs
Publications
Resources
News & Events
Staff
Contact & Referrals

Tumor Vaccines
News & Events


2008 Wings of Hope for Melanoma Gala to Honor Dr. Kaufman

The gala, which takes place on Thursday, October 2, 2008, is held by the Melanoma Research Foundation.

Tumor Vaccines: First Study of Trovax for Breast Cancer to Begin

Since 1997, the Tumor Immunotherapy Program has been at the forefront of efforts to beat cancer through the development of new vaccines. Led by Howard L. Kaufman, MD, Chief, Division of Surgical Oncology, the program conducts laboratory research and offers vaccines to patients with melanoma, colon cancer, kidney cancer, and other types of cancer including breast cancer.

Turning Back Advanced Cancers with IL-2

The Interleukin-2 Unit of the NewYork-Presbyterian Tumor Immunotherapy Program at Columbia University Medical Center uses interleukin-2, or IL-2, to treat patients who have malignant melanoma and advanced kidney cancer. IL-2 represents one of the best treatment options for patients with advanced melanoma and kidney cancer.


Advances in Melanoma CME

DateSeptember 9, 2006
DescriptionSymposium to discuss emerging therapeutic strategies, including the current status of both adjuvant and neoadjuvant treatments with vaccines and biochemotherapy regimens for early-stage disease. In addition, the clinical utility of biologic therapies and the role of novel targeted agents in the clinical management of advanced malignant melanoma will be assessed.
ContactFor more information and registration, pleas visit www.Melanoma.CancerConferences.com.
Brochuredownload pdf brochure

NYC Melanoma Consortium Discussion Board

We are pleased to introduce the New York Melanoma Consortium Discussion Board, a place where patients can discuss experiences, share information, and get support from others.


Trial of New Vaccine for Stage IV Kidney Cancer

To contact the Tumor Vaccine Program about the TroVax-IL-2 trial, physicians may contact Gail DeRaffele, RN at 212.342.0232 or gd2023@columbia.edu.



Tumor Immunology Journal Club

LocationP&S 17-412, conference room
DayWednesdays, weekly
Time12:30–1:30pm

For schedules or if you would like to join our Journal Club, please call 212.342.6042.


Lab Meeting

LocationP&S 17-412, conference room
DayMondays, weekly
Time3:00–5:00pm

Melanoma Tumor Board

LocationIP-Garden Center Conference Room
DayTuesdays, weekly
Time12:00–1:00pm

To submit a case, please contact Gail deRaffele, RN at 212.342.0232 or gd2023@columbia.edu.


IL-2 SUPPORT GROUP

LocationMHB, 5-411 Conference Room
DayTuesdays, monthly
Time12:30–2:00pm

New York City Melanoma Consortium, Biannual Meeting

Location & Date to be determined.

For more information about the New York City Melanoma Consortium, please contact Gail deRaffele, RN at 212.342.0232 or gd2023@columbia.edu.


     Contact Us About Us  Ways to Give Site Map Disclaimer Find a Physician Patient Forms Intranet
Columbia University Medical Center NewYork-Presbyterian Hospital